Skip to main content
. 2020 Apr 14;2020:3647525. doi: 10.1155/2020/3647525

Table 2.

Primers used in this study.

Target GenBank number Primers sequence (5′-3′)
GAPDH NM_001206359 F: ACTCACTCTTCCACTTTTGATGCT
R: TGTTGCTGTAGCCAAATTCA
TLR4 NM_001113039.1 F: GCCATCGCTGCTAACATCATC
R: CTCATACTCAAAGATACACCATCGG
MyD88 NM_001099923.1 F: TGGTAGTGGTTGTCTCTGATGA
R: TGGAGAGAGGCTGAGTGCAA
NF-κB NM_001048232.1 F: CTCGCACAAGGAGACATGAA
R: ACTCAGCCGGAAGGCATTAT
IL-6 NM_001252429.1 F: TGGCTACTGCCTTCCCTACC
R: CAGAGATTTTGCCGAGGATG
IL-8 NM_213867.1 F: TTCGATGCCAGTGCATAAATA
R: CTGTACAACCTTCTGCACCCA
IL-10 HQ026020.1 F: GCTGAAGACCCTCAGGCTGA
R: GCTGAAGACCCTCAGGCTGA
TNF-α NM_214022.1 F: CCAATGGGCAGAHTGGGTATG
R: TGAAGAGGACCTGGGAGTAG

Note. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; TLR4, toll-like receptors 4; MyD88, myeloid differentiation factor 88; NF-κB, nuclear factor-κB; IL-6, interleukin-6; IL-8, interleukin-8; IL-10, interleukin-10; TNF-α, tumor necrosis factor-α.